A recent study found that NEAT1 expression is suppressed in the early stages of AD and that it inhibits neuroglial cells, mediating Aβ clearance via epigenetic regulation of the expression of endocytosis-related genes (CAV2, TGFB2, and TGFBR1) [137]. This evidence concerns the gene NEAT1 and Alzheimer disease.